Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02036086
Title Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sunnybrook Health Sciences Centre
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Additional content available in CKB BOOST